Alkermes
artistry safety summary safety profile of in combination with generally consistent with profile in combination no emerging evidence of additive toxicities to those already established for alone part only combination with part only chills pyrexia nausea hypotension are most frequently reported treatment related adverse events anticipated effects of administration transient majority grade in severity chills pyrexia fatigue are most frequently reported treatment related aes anticipated effects of administration transient all grade in severity most frequent grade was most frequent grade was count decrease no discontinuations due to treatment related aes no deaths due to treatment related aes discontinuation due to treatment related aes included fatigue pneumonitis infusion related reaction inanition two deaths in pancreatic cancer patients reported at one death due to inanition and assessed by the investigator as related to one death due to underlying cancer and assessed as unrelated to treatment data as of oolitic | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
63 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Results
June 2021
artistry safety summary | Alkermes
Related slides by other companies
Mink Therapeutics
Investor Day
November 2022
| Mink Therapeutics
Kymera
Investor Presentation
December 2023
safety summary | Kymera
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io